Read More 1 minute read Analyst Ratings Where Phillips Edison Stands With Analysts By Benzinga Insights Today, 8:08 AM Within the last quarter, Phillips Edison (NASDAQ:PECO) has observed the following analyst ratings: PECO
Read More 1 minute read Analyst Ratings Downgrades News Price Target Mizuho Downgrades Phillips Edison to Neutral, Announces $35 Price Target By Benzinga Newsdesk Today, 8:08 AM Mizuho analyst Haendel St. Juste downgrades Phillips Edison (NASDAQ:PECO) from Buy to Neutral and announces $35 price target. PECO
Read More 1 minute read Analyst Ratings News Price Target Morgan Stanley Maintains Equal-Weight on Phillips Edison, Lowers Price Target to $31 By Benzinga Newsdesk Today, 8:08 AM Morgan Stanley analyst Richard Hill maintains Phillips Edison (NASDAQ:PECO) with a Equal-Weight and lowers the price target from $32 to $31. PECO
Read More 20 minute read Analyst Ratings Downgrades Initiation Intraday Update Upgrades Benzinga’s Top Ratings Upgrades, Downgrades For June 23, 2022 By Benzinga Insights Today, 8:08 AM Upgrades AAP
Read More 1 minute read Analyst Ratings Initiation News Price Target Credit Suisse Initiates Coverage On Phillips Edison with Neutral Rating, Announces Price Target of $34 By Benzinga Newsdesk Today, 8:08 AM Credit Suisse analyst Omotayo Okusanya initiates coverage on Phillips Edison (NASDAQ:PECO) with a Neutral rating and announces Price Target of $34. PECO
Read More 1 minute read Analyst Ratings 4 Analysts Have This to Say About Phillips Edison By Benzinga Insights Today, 8:08 AM Within the last quarter, Phillips Edison (NASDAQ:PECO) has observed the following analyst ratings: PECO
Read More 1 minute read Analyst Ratings News Price Target Morgan Stanley Maintains Equal-Weight on Phillips Edison, Lowers Price Target to $32 By Benzinga Newsdesk Today, 8:08 AM Morgan Stanley maintains Phillips Edison (NASDAQ:PECO) with a Equal-Weight and lowers the price target from $37 to $32. PECO
Read More 30 minute read Earnings Markets News Pre-Market Outlook Earnings Scheduled For May 5, 2022 By Benzinga Insights Today, 8:08 AM Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million. AAOI
Read More 10 minute read Analyst Ratings Downgrades Initiation Intraday Update Upgrades Benzinga’s Top Ratings Upgrades, Downgrades For March 9, 2022 By Benzinga Insights Today, 8:08 AM Upgrades ADP
Read More 1 minute read Analyst Ratings Expert Ratings For Phillips Edison By Benzinga Insights Today, 8:08 AM Phillips Edison (NASDAQ:PECO) has observed the following analyst ratings within the last quarter: PECO